Glutathione (Liposomal)
Liposomal glutathione · Glutathione supplementation · Glutathione · GSH
Snapshot
| Indications | Contraindications |
|---|---|
Glutathione is a tripeptide that serves as the cell's main redox buffer, supporting antioxidant defense and detoxification7. Liposomal and other oral forms are taken to raise glutathione status, mainly for skin lightening, oxidative stress in type 2 diabetes, and Parkinson's disease, where trials are few.
Randomized trials found oral glutathione lowered melanin index versus placebo, though one multicenter trial of a combination supplement did not reach significance1. Reviews in type 2 diabetes and Parkinson's disease call the evidence preliminary2, 3. Liposomal and other delivery forms may improve availability, but clinical benefit is unproven7. A 2025 case report described systemic inflammatory response syndrome after a high-dose intravenous glutathione infusion given for skin lightening; no trial has tested that risk. Products listing glutathione are mostly liquids and capsules; see Form comparison.
Intravenous use is where caution concentrates: a 2025 systematic review judged it contraindicated for skin lightening, citing lack of efficacy and side effects1. Product choice matters too: the United States (US) Food and Drug Administration (FDA) import alerts record a product manifested as glutathione that held undeclared human growth hormone8. Health Canada lists a practitioner's advice before use in pregnancy or breastfeeding on licensed oral products9.
Last updated October 16, 2026. Read how we make monographs.
In the full monograph
62 sources, 53 studies
- When to useThe situations practitioners use it for, each with the reason and the study behind it.
- SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
- InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
- Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
- How it worksWhat it is and how it works in the body, in plain terms.
- Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
- Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
- Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.
Sources
- 1Glutathione as a skin-lightening agent and in melasma: a systematic review.pubmed.ncbi.nlm.nih.govSarkar, Yadav, Yadav et al. · International journal of dermatology · 2025 · Pubmed
- 2Efficacy and Safety of Glutathione Supplementation in Type 2 Diabetes & Diabetes Complications.pubmed.ncbi.nlm.nih.govAu, Dawi, Affa et al. · Nutrients · 2026 · Pubmed
- 3The role of N-acetylcysteine and glutathione in the management of Parkinson's disease: a systematic review of oxidative biomarkers and clinical outcomes.pubmed.ncbi.nlm.nih.govMohammed, Nankya, Hong et al. · Amino acids · 2026 · Pubmed
- 4Systemic Inflammatory Response Syndrome Following High-Dose Intravenous Glutathione-Containing Revitalising Solution in a Patient on Tirzepatide: A Case Report.pubmed.ncbi.nlm.nih.govSharma, Daram, Sharma · Cureus · 2025 · Pubmed
- 5Foreign drug labelema.europa.euThe label of a medicine with this ingredient approved outside the US (a regulator's Summary of Product Characteristics or prescribing information, or the manufacturer's official instructions). Labels in German, Italian or Russian are quoted in English translation, marked as translated. What one country approved for one product, not US approval
- 6US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
- 7Glutathione in redox homeostasis: Bridging molecular mechanisms, bioavailability constraints, and translational challenges in systemic therapeutics.pubmed.ncbi.nlm.nih.govCarnib, Matos, Lage et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026 · Pubmed
- 8FDA actionsfda.govFDA warning letters, import alerts and Pharmacy Compounding Advisory Committee documents that name this ingredient, in the FDA's words. Findings about products sold and a regulator's review, not evidence of harm from the ingredient itself
- 9Health Canadahealth-products.canada.caLabel statements and adult daily amounts Health Canada authorized on licensed natural health products with this ingredient alone, from the Licensed Natural Health Products Database. Contains information licensed under the Open Government Licence – Canada